Tuesday, November 24, 2009, 10:24pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

BioMarin Pharmaceutical Inc. (BMRN)

 At 16:00 EST: 16.67 USD  Down 0.30 (1.77%)  
MORE ON BMRN
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
BioMarin Pharmaceutical Inc. (NasdaqNM:BMRN) Delayed quote dataEdit
After Hours: 16.67 0.00 (0.00%) as of 4:59pm EST on 11/24/09
Last Trade: 16.67 USD
Trade Time: 4:00PM EST
Change: Down 0.30 (1.77%)
Prev Close: 16.97
Open: 16.89
Bid: 16.16 x 100
Ask: 17.11 x 100
1y Target Est: 43.83
Day's Range: 16.60 - 17.08
52wk Range: 9.93 - 21.23
Volume: 1,034,352
Avg Vol (3m): 1,410,940
Market Cap: 1.68B
P/E (ttm): N/A
EPS (ttm): -0.30
Div & Yield: N/A (N/A%)
BioMarin Pharmaceutical Inc. (BMRN)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add BMRN to Portfolio   Download Data

HEADLINES
• BioMarin to Present at the NASDAQ OMX 23rd Investor Program
PRNewswire (Tue 4:00pm)
• Particles Detected in Vials from Genzyme's Plant Not Expected to Impact Aldurazyme or Naglazyme
PRNewswire (Fri, Nov 13)
• Healthcare Bill Will Be Law By New Year Says Morningstar Strategist
Wall Street Transcript (Mon, Nov 9)
• United States Patent Office Issues Patent Covering the Approved Administration of Kuvan With Food
PRNewswire (Thu, Nov 5)
• BioMarin to Present at the Credit Suisse Healthcare Conference
PRNewswire (Wed, Nov 4)
• BIOMARIN PHARMACEUTICAL INC Financials
EDGAR Online Financials (Tue, Nov 3)
• Finally Convinced? Benlysta Works!
at Motley Fool (Mon, Nov 2)
• Earnings? Yawn. Trial Data? Moving!
at Motley Fool (Fri, Oct 30)
• This Week's 5 Smartest Stock Moves
at Motley Fool (Fri, Oct 30)
• BIOMARIN PHARMACEUTICAL INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Oct 29)
More Headlines for BMRN...
ANALYST
EPS Est (next year) (Dec-07) : -0.15
EPS Est (in 2 years) (Dec-08) : 0.49
Avg Rec (current)*: 1.3
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
BioMarin Pharmaceutical, Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprised of approved products and various investigational product candidates.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices